跳至主要内容
临床试验/NCT02563730
NCT02563730Unknown不适用

Open Label Trial of Utility of Cryobiopsy in the Multidisciplinary Diagnosis of Idiopathic Interstitial Lung Disease

University Hospital Tuebingen11 个研究点 分布在 4 个国家目标入组 100 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
11
主要终点
Percentage of conclusive diagnosis after bronchoscopy with transbronchial cryobiopsy

研究概览

简要总结

A multicenter, multinational, prospective study to clarify, whether the addition of cryobiopsy can avoid surgical lung biopsy in a clinically relevant proportion of patients with suspected Idiopathic Interstitial Pneumonia

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • IIP suspected on clinical and radiologic grounds

排除标准

  • Age >80y and <18y
  • FVC< 55%, DCO<35%
  • Platelet count <100000/µl
  • acetylsalicylic acid, clopidogrel or equivalent during the last 5 days
  • INR > l,3,
  • elevated PTT (> 40 s)
  • documented pulmonary hypertension PAPS >50mmHg
  • HR-CT highly suspicious for sarcoidosis

结局指标

主要结局

Percentage of conclusive diagnosis after bronchoscopy with transbronchial cryobiopsy

时间窗: two weeks

次要结局

  • Influence of the size of the cryoprobe in the primary endpoint(2 weeks)
  • Rate of exacerbations after cryobiopsy and after surgical biopsy(6 weeks)
  • numer of exacerbations after biopsy(6 weeks)
  • Quality of specimen(2 weeks)
  • numer of bleeding events(1 day)
  • Rate of pneumothoraxes(1 day)
  • Size of specimen(2 weeks)
  • Distribution of histological changes in the specimen(2 weeks)
  • Contribution of BAL and cryobiopsy to diagnosis(2 weeks)
  • Comparative group (out of trial) - who are referred for VATS directly ['positive control group'](6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Boeckeler, Michael

MD

University Hospital Tuebingen

研究点 (11)

Loading locations...

相似试验